Articles
MyIDT2D offers a wealth of knowledge and information about Type 2 Diabetes. Our latest articles are written by renowned experts in the field and are designed to keep you up-to-date with the latest developments. By staying informed, you can make informed decisions about your health and manage your condition effectively. Please feel free to share your thoughts with us in the comment section. We value your feedback and look forward to hearing from you!
More than 50,000 patients will be affected by the Danish Medicines Agency's decision that patients will not receive subsidies for Novo Nordisk's diabetes medicine Ozempic - unless other, treatment have been tried first.
The public subsidy is changing to GLP-1 medication for Type 2 diabetes. Naturally, this raises concerns among many of our members.
Summary of article from the Danish Medicines Agency, click the link to read the full article and why the rules are changing:
The Danish Medicines Agency has made decisions regarding future subsidies for type 2 diabetes medication that is not based on insulin. While most types of diabetes medication will retain their subsidies, certain GLP-1 analogs will face stricter conditions for their subsidies. These changes will take effect from November 25, 2024.
Decisions on medication subsidies take into account factors such as treatment rationale and whether medication prices are in line with their therapeutic effects. GLP-1 analogs such as Ozempic, Trulicity, Rybelsus, and Victoza are significantly more expensive than other types of diabetes medication. Despite recommendations to use cheaper alternatives, many patients have been prescribed GLP-1 analogs directly without trying these alternatives first.
To address this challenge, the Danish Medicines Agency has recommended a transition from general subsidies to individual subsidies for GLP-1 analogs. Additionally, the price of the most commonly used GLP-1 analog, Ozempic, has been reduced by 34% since April 29, 2024. Despite this reduction, GLP-1 analogs remain more expensive than other brands of diabetes medication.
The agency aims to reduce public spending on medication subsidies while ensuring rational medication use. Patients are encouraged to consult their doctors regarding any changes to their diabetes medication and to check for updates on medication subsidies on the Danish Medicines Agency's website or at their local pharmacy.
Overall, the decision aims to adhere to medical guidelines, reduce public spending, and streamline the process for both patients and healthcare providers.
Ozempic® generally receives a conditional subsidy
We are still awaiting the final announcement from LMST regarding changes to subsidy regulations, but it is already recommended to reconsider whether each patient can be switched from GLP1 agonists to equivalent and cheaper alternatives.
​
Many patients would benefit from and tolerate much cheaper medications such as SU or DPP4 inhibitors. SGLT-2 inhibitors are clinically equivalent to GLP1 agonists for patients with recognized or very high risk of cardiovascular disease, and since GLP1 agonists are more than twice as expensive, it is rational to try an SGLT-2 inhibitor first.
​
For recognized kidney disease or heart failure, SGLT-2 inhibitors are clinically the best choice. Even in patients with severe obesity with diabetes, there is often no clinical evidence to prefer a GLP1 agonist.
​
Common Meds Link to Sudden Cardiac Arrest in Type 2 Diabetes
- Studies have shown that people with type 2 diabetes who do not have a history of cardiovascular disease (CVD) are at an increased risk of SCA if they take certain medications such as antipsychotics or antibiotics that prolong the QT interval, specifically macrolides and fluoroquinolones.
At MyIDT2D, we urge those with type 2 diabetes to discuss any potential risks associated with medications with their healthcare providers before starting any new medications.
​
Testosterone Replacement Benefits Men With Type 2 Diabetes
- If you're a man with type 2 diabetes, it's important to consider the benefits of testosterone replacement. MyIDT2D is here to help you understand the benefits of this natural therapy. We specialize in helping men with type 2 diabetes improve their health and quality of life. Contact us today to learn more.
​
Overcoming the Stigma of Type 2 Diabetes (Danish Project)
- Living with Diabetes Type 2 can be challenging enough without the added burden of stigma. MyIDT2D is working to raise awareness of the consequences of stigma on individuals with this condition, as well as the mediating factors that can help to reduce it. By addressing the underlying causes of stigma and promoting understanding and empathy, we hope to create a more supportive and inclusive environment for those living with this condition.
​
Click here to read the entire Danish Project about the stigma and consequences
Newly Diagnosed with Type 2 Diabetes?
- At MyIDT2D, we believe that no one should face type 2 diabetes alone. Our team of healthcare professionals is here to provide you with the support and resources you need to live a healthy and fulfilling life. From educational materials to personalized care plans, we are dedicated to helping you manage your condition and reduce your risk of complications. Contact us today to learn more about how we can help.
​
Click here to read the entire article from Videncenterfordiabetes
Diabetes stress can affect us all
- If you're dealing with diabetes, you likely understand what it's like to experience diabetes stress. At MyIDT2D, we're here to help you manage your diabetes and navigate the stress that comes along with it. We know that it can be tough to keep up with doctor appointments, taking medication, and monitoring your blood sugar levels while also dealing with the emotional impact of living with diabetes. Our organization is dedicated to providing the resources, education, and support you need to manage your diabetes stress and live well with diabetes.
​
Click here to read the entire article from Videncenterfordiabetes
​
Anxiety and Type 2 Diabetes
- At MyIDT2D, we understand that anxiety can impact those with type 2 diabetes. It's important to recognize the symptoms of anxiety, such as feeling restless or overwhelmed. Seeking help is a sign of strength, and our team of healthcare professionals is here to support you. Don't hesitate to reach out and schedule an appointment with your provider to discuss your symptoms and treatment options.
​
Click here to read the entire article from Videncenterfordiabetes